SMI
11.990,27
PKT
+48,27
PKT
+0,40
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.04.17 | Roche Reduce | HSBC | |
07.04.17 | Nestlé buy | Goldman Sachs Group Inc. | |
06.04.17 | Novartis Neutral | UBS AG | |
06.04.17 | Holcim buy | Deutsche Bank AG | |
06.04.17 | Swiss Re Equal weight | Barclays Capital | |
05.04.17 | UBS buy | UBS AG | |
05.04.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
05.04.17 | Nestlé buy | UBS AG | |
05.04.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
05.04.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
05.04.17 | Swiss Re Outperform | Robert W. Baird & Co. Incorporated | |
05.04.17 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.04.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
04.04.17 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
03.04.17 | Holcim buy | HSBC | |
03.04.17 | Roche overweight | JP Morgan Chase & Co. | |
03.04.17 | Holcim Neutral | JP Morgan Chase & Co. | |
31.03.17 | Nestlé Equal weight | Barclays Capital | |
30.03.17 | Givaudan Hold | Deutsche Bank AG | |
30.03.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
30.03.17 | Roche overweight | JP Morgan Chase & Co. | |
29.03.17 | Zurich Insurance Hold | Baader Bank | |
28.03.17 | UBS buy | Citigroup Corp. | |
28.03.17 | UBS buy | Citigroup Corp. | |
28.03.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
28.03.17 | Givaudan overweight | JP Morgan Chase & Co. | |
28.03.17 | Nestlé overweight | JP Morgan Chase & Co. | |
28.03.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
27.03.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
27.03.17 | Givaudan Hold | Deutsche Bank AG | |
27.03.17 | UBS buy | Goldman Sachs Group Inc. | |
27.03.17 | Nestlé Hold | Jefferies & Company Inc. | |
27.03.17 | UBS buy | HSBC | |
24.03.17 | Nestlé buy | Deutsche Bank AG | |
23.03.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
23.03.17 | Novartis buy | Kepler Cheuvreux | |
23.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
23.03.17 | Roche buy | Société Générale Group S.A. (SG) | |
23.03.17 | Novartis Neutral | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.